Drugs that Mimic the Effect of Gene Mutations for the Prevention or the Treatment of Atherosclerotic Disease: From PCSK9 Inhibition to ANGPTL3 Inactivation
Year: 2018
Type: article
Source: Current Pharmaceutical Design
Authors: Vasilios G. Athyros, Niki Katsiki, Aikaterini Dimakopoulou, Dimitrios Patoulias, Sofia Alataki, Michael Doumas
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: PCSK9 inhibition, ANGPTL3, familial hypercholesterolemia, loss-of-function mutations, evolocumab, alirocumab, evinacumab, LDL cholesterol lowering, triglycerides, atherosclerosis, cardiovascular disease prevention, antisense oligonucleotides, microRNA-27b, apolipoprotein C-III, lipid-lowering drugs, dyslipidemia
Open Access status: closed
Funders: Eli Lilly and Company, Pfizer, Servier
OpenAlex ID: W2896481055
